GRCh38/hg38 15q11.2(chr15:22572809-23066575)x3 AND See cases

Germline classification:: Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:: Oct 19, 2010
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000135477.11

Allele description [Variation Report for GRCh38/hg38 15q11.2(chr15:22572809-23066575)x3]

GRCh38/hg38 15q11.2(chr15:22572809-23066575)x3

Genes:

LOC130056712:ATAC-STARR-seq lymphoblastoid active region 9154 [Gene]
LOC130056713:ATAC-STARR-seq lymphoblastoid active region 9155 [Gene]
LOC130056714:ATAC-STARR-seq lymphoblastoid active region 9156 [Gene]
LOC130056715:ATAC-STARR-seq lymphoblastoid active region 9157 [Gene]
LOC130056716:ATAC-STARR-seq lymphoblastoid active region 9158 [Gene]
LOC130056717:ATAC-STARR-seq lymphoblastoid active region 9159 [Gene]
LOC130056718:ATAC-STARR-seq lymphoblastoid active region 9160 [Gene]
LOC130056707:ATAC-STARR-seq lymphoblastoid silent region 6257 [Gene]
LOC130056708:ATAC-STARR-seq lymphoblastoid silent region 6258 [Gene]
LOC130056709:ATAC-STARR-seq lymphoblastoid silent region 6259 [Gene]
LOC130056710:ATAC-STARR-seq lymphoblastoid silent region 6260 [Gene]
LOC130056711:ATAC-STARR-seq lymphoblastoid silent region 6261 [Gene]
LOC126862074:CDK7 strongly-dependent group 2 enhancer GRCh37_chr15:22990202-22991401 [Gene]
NIPA1:NIPA magnesium transporter 1 [Gene - OMIM - HGNC]
NIPA2:NIPA magnesium transporter 2 [Gene - OMIM - HGNC]
LOC112272576:Sharpr-MPRA regulatory region 3977 [Gene]
LOC112272575:Sharpr-MPRA regulatory region 8478 [Gene]
CYFIP1:cytoplasmic FMR1 interacting protein 1 [Gene - OMIM - HGNC]
TUBGCP5:tubulin gamma complex component 5 [Gene - OMIM - HGNC]
LOC283683:uncharacterized LOC283683 [Gene]

Variant type:

copy number gain

Cytogenetic location:

15q11.2

Genomic location:

Preferred name:

GRCh38/hg38 15q11.2(chr15:22572809-23066575)x3

HGVS:

NC_000015.10:g.(?_22572809)_(23066575_?)dup
NC_000015.8:g.(?_20249886)_(20851728_?)dup
NC_000015.9:g.(?_22698522)_(23300287_?)dup

Links:

dbVar: nssv576845; dbVar: nssv582016; dbVar: nssv707166; dbVar: nsv529157

Observations:

Condition(s)

Name:: See cases [See the Variation display for details]
Identifiers:

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000175214	ISCA site 8 See additional submitters International Standards For Cytogenomic Arrays Consortium (ISCA)	no assertion criteria provided	Uncertain significance (Oct 19, 2010)	unknown	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV000196262	ISCA site 17 See additional submitters International Standards For Cytogenomic Arrays Consortium (ISCA)	no assertion criteria provided	Benign (Jul 30, 2009)	unknown	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV000196263	ISCA site 4 See additional submitters International Standards For Cytogenomic Arrays Consortium (ISCA)	no assertion criteria provided	Benign (Jan 30, 2010)	unknown	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000175214

ISCA site 8

See additional submitters

no assertion criteria provided

Uncertain significance
(Oct 19, 2010)

unknown

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000196262

ISCA site 17

See additional submitters

no assertion criteria provided

Benign
(Jul 30, 2009)

unknown

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000196263

ISCA site 4

See additional submitters

no assertion criteria provided

Benign
(Jan 30, 2010)

unknown

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	not provided	yes	3	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, et al.

Am J Hum Genet. 2010 May 14;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006. Review.

PubMed [citation]

PMID:: 20466091
PMCID:: PMC2869000

Details of each submission

From ISCA site 8, SCV000175214.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	yes	not provided	not provided	Discovery		1	not provided	not provided	not provided

From ISCA site 17, SCV000196262.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	yes	not provided	not provided	Discovery		1	not provided	not provided	not provided

From ISCA site 4, SCV000196263.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	yes	not provided	not provided	Discovery		1	not provided	not provided	not provided

Last Updated: May 7, 2024

ClinVar

Relating variation to medicine